• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SPRINT 研究结果对高血压指南的影响:对“虚弱”老年患者的启示。

Impact of SPRINT results on hypertension guidelines: implications for "frail" elderly patients.

机构信息

Department of Translational Medical Sciences, University of Naples "Federico II", Naples, Italy.

Istituti Clinici Scientifici Maugeri- Syncope unit - UOC Cure sub-acute, Milan, Italy.

出版信息

J Hum Hypertens. 2018 Sep;32(8-9):633-638. doi: 10.1038/s41371-018-0086-6. Epub 2018 Jul 10.

DOI:10.1038/s41371-018-0086-6
PMID:29991704
Abstract

In the last years, guidelines for the treatment of hypertension recommended individualized blood pressure goals for geriatric population because of elderly susceptibility to adverse outcomes and higher mortality rate deriving from the excessive blood pressure lowering, especially in "frail" elderly. Recent findings from the SPRINT study, which demonstrated that intensive blood pressure lowering was associated with lower rates of cardiovascular events and mortality in both hypertensive fit and frail elderly subjects compared to standard treatment, heavily influenced the recent US guidelines. In SPRINT sub-study analysis of adults aged ≥75 years, the most controversial issue appears the method of blood pressure measurement, the selection of patients and related-frailty degree that appears to be very light. Accordingly, it has been described that light frailty is related to good outcomes in older adults. SPRINT findings in "frail elderly patients" cannot be applied to the clinical practice because this condition has been clearly under-estimated. Thus, frailty status should be routinely and correctly quantified in order to identify the frailty degree and to find the best harms-benefits balance of antihypertensive drug treatment in frail older adults.

摘要

在过去的几年中,高血压治疗指南建议为老年人群制定个体化的血压目标,因为老年人易发生不良后果,且血压降得过低会导致更高的死亡率,尤其是在“虚弱”的老年人中。SPRINT 研究的最新发现表明,与标准治疗相比,强化降压可降低高血压健康和虚弱老年人的心血管事件和死亡率,这对最近的美国指南产生了重大影响。SPRINT 研究对年龄≥75 岁成年人的亚组分析中,最具争议的问题似乎是血压测量方法、患者选择以及相关的虚弱程度,后者似乎非常轻微。因此,有人描述说轻度虚弱与老年人的良好结局有关。SPRINT 研究在“虚弱老年患者”中的发现不能应用于临床实践,因为这种情况显然被低估了。因此,应常规正确地量化虚弱状态,以确定虚弱程度,并找到在虚弱的老年高血压患者中进行降压药物治疗的最佳利弊平衡。

相似文献

1
Impact of SPRINT results on hypertension guidelines: implications for "frail" elderly patients.SPRINT 研究结果对高血压指南的影响:对“虚弱”老年患者的启示。
J Hum Hypertens. 2018 Sep;32(8-9):633-638. doi: 10.1038/s41371-018-0086-6. Epub 2018 Jul 10.
2
Blood pressure strategies and goals in elderly patients with hypertension.老年高血压患者的血压管理策略与目标
Exp Gerontol. 2017 Jan;87(Pt B):151-152. doi: 10.1016/j.exger.2016.04.018. Epub 2016 Apr 25.
3
Hypertension Management in Older and Frail Older Patients.老年及虚弱老年患者的高血压管理。
Circ Res. 2019 Mar 29;124(7):1045-1060. doi: 10.1161/CIRCRESAHA.118.313236.
4
Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial.在收缩压干预试验中对衰弱状态进行特征描述。
J Gerontol A Biol Sci Med Sci. 2016 May;71(5):649-55. doi: 10.1093/gerona/glv228. Epub 2016 Jan 11.
5
Hypertension in the frail elderly.老年体弱者的高血压
J Am Soc Hypertens. 2016 Jun;10(6):536-41. doi: 10.1016/j.jash.2016.03.187. Epub 2016 Mar 26.
6
Pharmacological management of hypertension in the elderly and frail populations.老年人和体弱人群的高血压药物治疗管理。
Expert Rev Clin Pharmacol. 2018 Aug;11(8):805-817. doi: 10.1080/17512433.2018.1500896. Epub 2018 Jul 23.
7
Blood Pressure in Older Adults: the Importance of Frailty.老年人的血压:衰弱的重要性。
Curr Hypertens Rep. 2015 Jul;17(7):55. doi: 10.1007/s11906-015-0564-y.
8
[Which blood pressure target for the frail older patient?].体弱老年患者的血压目标是多少?
Ned Tijdschr Geneeskd. 2023 Mar 15;167:D7334.
9
Management of Hypertension in the Elderly and Frail Elderly.老年及体弱老年人高血压的管理
High Blood Press Cardiovasc Prev. 2017 Mar;24(1):1-11. doi: 10.1007/s40292-017-0185-4. Epub 2017 Feb 8.
10
Hypertension in frail older adults: current perspectives.衰弱老年人的高血压:当前观点。
PeerJ. 2024 Jul 11;12:e17760. doi: 10.7717/peerj.17760. eCollection 2024.

引用本文的文献

1
Deprescribing Cardiovascular Medications in Older Adults Living with Frailty.老年体弱患者停用心血管药物
CJC Open. 2024 Sep 25;6(12):1503-1512. doi: 10.1016/j.cjco.2024.09.008. eCollection 2024 Dec.
2
A scoping review of the measurement and analysis of frailty in randomised controlled trials.一项关于随机对照试验中衰弱测量和分析的范围综述。
Age Ageing. 2024 Nov 1;53(11). doi: 10.1093/ageing/afae258.
3
Prevalence and correlates of frailty in older hypertensive outpatients according to different tools: the HYPER-FRAIL pilot study.

本文引用的文献

1
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师协会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药学协会/美国血液学会/美国预防医学学会/美国医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13.
2
The Italian version of the "frailty index" based on deficits in health: a validation study.基于健康缺陷的“衰弱指数”意大利语版本:一项验证研究。
Aging Clin Exp Res. 2017 Oct;29(5):913-926. doi: 10.1007/s40520-017-0793-9. Epub 2017 Jul 7.
3
根据不同工具评估老年高血压门诊患者衰弱的流行情况及其相关因素:HYPER-FRAIL 先导研究。
J Hypertens. 2024 Jan 1;42(1):86-94. doi: 10.1097/HJH.0000000000003559. Epub 2023 Oct 3.
4
The degree of frailty as a translational measure of health in aging.衰弱程度作为衡量衰老健康的转化指标。
Nat Aging. 2021 Aug;1(8):651-665. doi: 10.1038/s43587-021-00099-3. Epub 2021 Aug 12.
5
Hypertension in the older person: is age just a number?老年人高血压:年龄只是一个数字吗?
Intern Med J. 2022 Nov;52(11):1877-1883. doi: 10.1111/imj.15949. Epub 2022 Nov 3.
6
Management of Hypertension in the Elderly and Frail Patient.老年和虚弱患者的高血压管理。
Drugs Aging. 2022 Oct;39(10):763-772. doi: 10.1007/s40266-022-00966-7. Epub 2022 Jul 29.
7
A clinical algorithm to determine target blood pressure in the elderly: evidence and limitations from a clinical perspective.一种确定老年人目标血压的临床算法:从临床角度看证据与局限性
Clin Hypertens. 2022 Jun 15;28(1):17. doi: 10.1186/s40885-022-00202-9.
8
Is Blood Pressure Lowering in the Very Elderly With Previous Stroke Associated With a Higher Risk of Adverse Events?非常高龄且既往有卒中史患者的降压治疗与不良事件风险增加相关吗?
J Am Heart Assoc. 2021 Dec 21;10(24):e022240. doi: 10.1161/JAHA.121.022240. Epub 2021 Dec 16.
9
Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people.观察到的和预期的高血压随机临床试验中的严重不良事件发生率:一项观察性研究比较了关注和不关注老年人的试验。
Lancet Healthy Longev. 2021 Jul;2(7):e398-e406. doi: 10.1016/S2666-7568(21)00092-1.
10
Brazilian Guidelines of Hypertension - 2020.《巴西高血压指南 - 2020》
Arq Bras Cardiol. 2021 Mar;116(3):516-658. doi: 10.36660/abc.20201238.
Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.加拿大高血压学会 2017 年成人高血压诊断、风险评估、预防和治疗指南。
Can J Cardiol. 2017 May;33(5):557-576. doi: 10.1016/j.cjca.2017.03.005. Epub 2017 Mar 10.
4
Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians.《成年人 60 岁及以上患者高血压治疗:血压目标值更高或更低的药物治疗:美国医师学会和美国家庭医生学会临床实践指南》。
Ann Intern Med. 2017 Mar 21;166(6):430-437. doi: 10.7326/M16-1785. Epub 2017 Jan 17.
5
Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older: A Systematic Review and Meta-analysis.老年人(年龄≥60 岁)强化降压治疗的获益与危害:系统评价与荟萃分析。
Ann Intern Med. 2017 Mar 21;166(6):419-429. doi: 10.7326/M16-1754. Epub 2017 Jan 17.
6
Isolated Systolic Hypertension: An Update After SPRINT.单纯收缩期高血压:SPRINT 后的更新。
Am J Med. 2016 Dec;129(12):1251-1258. doi: 10.1016/j.amjmed.2016.08.032. Epub 2016 Sep 14.
7
Systolic blood pressure and cardiovascular mortality in middle-aged and elderly adults - The Singapore Chinese Health Study.中年及老年成年人的收缩压与心血管死亡率——新加坡华人健康研究
Int J Cardiol. 2016 Sep 15;219:404-9. doi: 10.1016/j.ijcard.2016.06.033. Epub 2016 Jun 14.
8
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.强化与标准血压控制对≥75岁成年人心血管疾病结局的影响:一项随机临床试验。
JAMA. 2016 Jun 28;315(24):2673-82. doi: 10.1001/jama.2016.7050.
9
Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials.收缩压干预试验中的非 attended 血压测量:与其他试验相比,对入选血压值和实际达到的血压值的影响。 (注:“Unattended”原词有误,推测可能是“Untended”,若为“Untended”,准确译文为:收缩压干预试验中的非监护血压测量:与其他试验相比,对入选血压值和实际达到的血压值的影响。 )
Hypertension. 2016 May;67(5):808-12. doi: 10.1161/HYPERTENSIONAHA.116.07257. Epub 2016 Mar 21.
10
Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial.在收缩压干预试验中对衰弱状态进行特征描述。
J Gerontol A Biol Sci Med Sci. 2016 May;71(5):649-55. doi: 10.1093/gerona/glv228. Epub 2016 Jan 11.